Webinář - Prozkoumat pro Huntington: Dobrodružství Dimitriho Poffé v Latinské Americe

To finish May Awareness Month in the most inspiring and hopeful way possible, the International Huntington Association and European Huntington Association had a webinar with Dimitri Poffé, a Huntington’s Disease […]
Rozsviťte to pro Huntingtonovu chorobu 2022

It’s HD May Awareness Month and HDSI (Huntington’s Disease Society of India) is celebrating it with HD light-up, by lighting up buildings of proeminence in order to express solidarity with […]
Polsko a Belgie stojí v čele úsilí o pomoc ukrajinským rodinám s vysokým rozlišením

If the situation in Ukraine isn’t desperate enough, spare a thought for those with the added burden of Huntington’s Disease. Danuta Lis, president of the Polish HD Association and Bea De […]
Webinář - Vše, co potřebujete vědět o technologii Proof-HD

Yesterday, Prilenia hosted a webinar updating on the Phase III trial with Pridopidine. Thank you to everyone who join and a special thanks to our speakers, Michael Hayden, Andrew Feigin, […]
1. konference o vzácných onemocněních v oblasti MENA

Od 18. do 20. února se v Dubaji uskuteční první konference o vzácných onemocněních v oblasti MENA (Blízký východ a severní Afrika), jejímž vědeckým partnerem je Mezinárodní huntingtonská asociace. Tato akce se koná v rámci projektu [...]
HDYO spustí JOIN-HD, globální registr pro mladistvé s výskytem HD.

HDYO will launch JOIN-HD, the Juvenile onset HD Global Registry, that will be open for Stage 1: Open Enrollment, starting February 4th. JOIN-HD is a global registry that collects experiences […]
Mezinárodní virtuální kongres HDYO pro mladé dospělé

Welcome to HDYO’s International Young Adult Virtual Congress March 5-6, 2022! After the success of our first event, we’re hosting another virtual congress! Join us for two days of sensational […]
Učení příkladem: HD-JUNIOR národní registr pacientů s juvenilní formou Huntingtonovy choroby

Educational webinars on rare neurological, neuromuscular and movement disorders jointly organized by the European Reference Networks for Rare Neurological Diseases (ERN-RND) and Neuromuscular Diseases (ERN-EuroNMD) and the European Academy of […]
Přelomové zprávy - Roche plánuje novou studii Tominersenu

Some encouraging news has just come in from Roche. Analysis of the results of Roche’s Phase III GENERATION HD1 trial, which was stopped in March 2021, has found that a […]
Pocta velkému muži - Gerrit Dommerholt

It is with great sadness we announce the passing of one of our founders. Gerrit Dommerholt passed away in the Netherlands on the 31st December. Gerrit’s contribution to HD can hardly […]